HeXun Biosciences Co., Ltd.

HeXun Biosciences Co., Ltd. is a biotechnology company focused on the research and development of stem cell therapies and innovative drug products. Founded in 2019 and based in Taoyuan City, Taiwan, HeXun Biosciences provides a range of specialized services including contract development and manufacturing (CDMO), cell therapy production, outsourced testing, and aseptic filling. The company's technical capabilities encompass both allogeneic mesenchymal stem cell drugs and autologous cell technologies, supporting advancements in regenerative medicine and targeted treatments. Its offerings also include advisory services, laboratory setup and information management systems, and compliance support for Good Tissue Practice standards. Serving primarily the domestic Taiwanese healthcare market, HeXun Biosciences occupies a significant niche in pharmaceutical innovation, contributing to the commercialization of cell-based therapies and supporting the broader biotechnology ecosystem through its tailored R&D and production expertise. With consistently high gross and net profit margins, the company demonstrates strong operational efficiency in an industry marked by rapid scientific progress and growing demand for personalized medicine.